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2Summary
A prototype endovascular electromechanical clot extraction device was fabricated using a 
combination of shape memory polymer (SMP) and shape memory nickel-titanium alloy (nitinol). 
Five embolic vascular occlusions were created in four rabbits by injecting thermally coagulated 
blood through a 4.0F catheter in the common carotid artery. Angiography immediately after clot 
injection showed complete or partial occlusion of the common carotid artery. Post-treatment 
angiography showed complete (2/5), partial (2/5), or no (1/5) restoration of blood flow.
Most strokes are caused by cerebral thrombo-embolic arterial occlusion and are 
conventionally treated with intravenous thrombolytic drugs. Drawbacks associated with this 
treatment, including the narrow (3-hour) therapeutic window and strict exclusion criteria 
imposed to mitigate the risk of hemorrhage, have prompted the development of alternative non-
pharmacological therapies. We report on the use of an electromechanical embolectomy device in 
a rabbit acute arterial occlusion model.
Description of Technique
Device Use and Fabrication
The prototype device consisted of an electromechanical microactuator mounted on the distal 
tip of either a Prowler-14 microcatheter (1.9F distal shaft, Cordis Corporation, Miami Lakes, FL) 
or a custom-made 1.5F stainless steel 55-cm long hypotube with a 20-cm long distal flexible coil 
section (Heraeus Vadnais, St. Paul, MN). A device is shown in Fig 1. The microactuator was 
comprised of a shape memory polymer (SMP) shell over a shape memory nickel-titanium alloy 
3(nitinol) wire backbone with attached copper leads to deliver a current. The microactuator 
maintains a straight rod shape until the applied current, provided by a dc power supply, induces 
electro-resistive (Joule) heating of the nitinol wire, causing the microactuator to transform into a 
corkscrew shape capable of retrieving a blood clot. At body temperature, the overlying SMP is in 
a glassy (high elastic modulus) state and maintains the nitinol corkscrew in a straight form for 
endovascular delivery. Once in position beyond the clot, Joule heating is initiated. As the
surrounding SMP is heated by conduction to its characteristic glass transition temperature (Tg ≈ 
80 °C), it transitions to its low-modulus rubbery state, allowing the nitinol to resume its 
corkscrew shape. When the current is turned off, the nitinol and the SMP cool and the elastic 
modulus of the SMP approaches its original glassy value, providing enhanced stiffness to the 
nitinol corkscrew and resistance to deformation (i.e., stretching) during blood clot extraction.
Superelastic nitinol wire (SE508 wire, Nitinol Devices & Components, Fremont, CA) with a 
diameter of 97 μm was wrapped around an aluminum mandrel and heated in a furnace at 500 °C 
for 10 min to program the corkscrew shape. The nitinol reverts to the programmed corkscrew
shape at temperatures at or above its Austenite finish temperature (Af = 5-18 °C). To route 
current flow through the nitinol corkscrew for Joule heating, two polyimide-insulated 40 AWG 
copper wire leads approximately 100 cm long were connected to the nitinol wire at each end of 
the corkscrew using gold crimp tubes which also served as radiopaque markers. The diameter of 
the copper wire including insulation was 95 μm. The copper wire lead attached at the distal end 
of the nitinol corkscrew was wound back around the length of the corkscrew (Fig 1), permitting
both copper wire leads to emerge from the same (proximal) end of the corkscrew.
A thermosetting urethane SMP formulation developed in-house (1) was used to encase the 
copper-wound nitinol. A teflon tube (inner diameter = 305 μm) was placed over the straightened 
4copper-wound nitinol corkscrew and the SMP resin was injected into the tube. The cast SMP 
resin was then thermally cured and the teflon tube was removed, revealing a straight SMP rod 
encapsulating the copper-wound nitinol wire.
Intervention
The animal experiments were conducted at the University of California Davis Medical 
Center (Sacramento, CA) in accordance with the National Institutes of Health Public Health 
Service Policy on Humane Care and Use of Laboratory Animals and approved by the 
Institutional Animal Care and Use Committees of the University of California, Davis, and
Lawrence Livermore National Laboratory. Five occlusions were treated in four anesthetized New 
Zealand White rabbits (weight 3-4 kg). A 4.0 French sheath was placed in the right or left 
femoral artery and a 4.0 F catheter was directed into the common carotid artery (CCA; lumen 
diameter 1.5-2.0 mm) under fluoroscopic and roadmap guidance using iohexol contrast 
(Omnipaque 300, Amersham Health, Princeton, NJ); baseline angiography was performed. 
Blood collected from a marginal ear vein was thermally coagulated and a clot 0.2-0.3 cm3 in 
volume was injected through the catheter into the CCA. Angiography was performed to evaluate 
the resulting vascular occlusion and additional clot was injected if necessary. Under fluoroscopic 
guidance, the clot extraction device was delivered through the catheter in its straight form, 
positioned into the external carotid artery (ECA) distal to the occlusion, and actuated to assume 
its corkscrew form by applying a dc current of 0.6-0.8 A for 3-5 s until actuation was complete 
(the copper-wound nitinol was visible by fluoroscopy). The device and catheter were then 
withdrawn simultaneously. The sheath was inspected and any lodged clot was collected. 
Angiography was performed after each extraction attempt. The results are summarized in Table 
1. Angiographic images of the second rabbit are shown in Fig 2.
5Discussion
Non-pharmacological vascular reperfusion methods have exhibited the potential to broaden 
stroke patient eligibility by extending the therapeutic time window and reducing the 
contraindications related to the risk of hemorrhage (2). In particular, the U.S. Food and Drug 
Administration recently approved the use of the Merci Retrieval System (Concentric Medical, 
Inc., Mountain View, CA), a spring-like endovascular thrombectomy device to retrieve the clot 
up to 8 hours after the onset of stroke (3, 4). In the clinical study evaluating the safety and 
efficacy of the Merci system, up to six extraction attempts were made before the effort was 
considered a failure, with three attempts made on average (4).  Similarly, in this study multiple
attempts were usually required. This may at least in part be due to the fact that fragmentation of 
the injected clot occurred due to the small lumen of the 4.0 F catheter, confirmed on benchtop 
injection of clot through the catheter.
Several potential performance-enhancing modifications to the current device have been 
identified, including a flexible distal tip, a tighter corkscrew, and a means of securing the clot 
(e.g., aspiration into the guide catheter) for withdrawal from the body. Flow arrest, as in the 
Merci system (2, 3), could facilitate clot extraction and reduce the risk of distal embolization. To 
reduce the risk of thermal injury to the vessel during device actuation, the actuation temperature 
(i.e., the Tg of the SMP) would be minimized but maintained sufficiently above body 
temperature to prevent spontaneous actuation in the body. The Tg of the SMP can be tailored 
from approximately 34 to 86 °C by adjusting the chemical composition (1). Because the glass 
transition is gradual, actuation can be achieved at temperatures  ~10 °C below the nominal Tg.
Previous studies of energy-dissipating interventional therapeutic devices that generate 
6temperatures and total energy dissipated on the same order-of-magnitude as the SMP-nitinol 
device have resulted in no thermal damage (5). Future studies may include histological 
examination of tissue harvested at the site of actuation at various post-treatment timepoints to 
assess the extent of thermal injury, if any. In addition, further studies are necessary in larger 
animals, as this would allow the use of larger catheters, injection of intact clot, and evaluation of 
the device in vessels similar in size to the human internal carotid artery.
This preliminary study suggests that an SMP-nitinol device may have application in the 
treatment of acute stroke or other thrombo-embolic disease.  
References
1. Wilson TS, Small W, IV, Benett WJ, et al. Shape memory polymer therapeutic devices for 
stroke. Proc SPIE 2005;6007:157-64
2. Nesbit GM, Luh G, Tien R, et al. New and future endovascular treatment strategies for 
acute ischemic stroke. J Vasc Interv Radiol 2004;15:S103-10
3. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of mechanical 
embolus removal in cerebral ischemia. Stroke 2004;35:2848-54
4. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in 
acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8
5. Maitland DJ, Metzger MF, Schumann D, et al. Photothermal properties of shape memory 
polymer micro-actuators for treating stroke. Lasers Surg Med 2002;30:1-11
7TABLE 1: Summary of mechanical embolectomy results
Rabbit
Occlusion 
Site
Angiographic 
Deficit
No. of 
Extraction 
Attempts
Clot 
Retrieved 
from Sheath?
Angiographic 
Findings Post-
Treatment
1 R CCA Filling defect 1 Yes Complete restoration
2 R CCA Complete occlusion 3 Yes Complete restoration
3 R CCA Complete occlusion 3 Yes Partial restoration
L CCA Complete occlusion 5 No Complete occlusion
4 R CCA Complete occlusion 5 Yes Partial restoration
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FIG 1. Electromechanical embolectomy device in its corkscrew form.
A, The SMP-nitinol corkscrew microactuator is mounted at the distal end of a microcatheter. 
The copper leads (and nitinol wire) extend from the proximal end of the microcatheter for 
connection to the power supply. A close-up of the microactuator showing the radiopaque gold 
markers (arrows) is shown in the inset. Scale divisions in millimeters.
B, Microscope image of the microactuator showing the copper-wound nitinol wire 
encapsulated by SMP. The diameter of the microactuator is 0.3 mm (0.012 in). Scale bar = 1 
mm.
9A B
C D
CCA
ECA
FIG 2. Angiographic images of the second rabbit.
A, Baseline angiogram of the right CCA and branch vessels acquired before clot injection.
B, Angiogram showing occlusion of the CCA.
C, Fluoroscopic image showing placement of the device into the ECA distal to the occlusion 
(radiopaque markers indicated by arrows). The copper-wound nitinol was visible on the 
fluoroscopy monitors but not on the video tape recording used to capture the image.
D, Post-treatment angiogram showing complete restoration of blood flow. A photograph of the 
retrieved clot is shown in the inset (scale divisions in millimeters).
